Renalytix Plc (RTNXF)
USD 0.08
(0.0%)
USD 0.08
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -30.11 Million | -32.67 Million | -45.74 Million | -24.63 Million | -10.06 Million | -3.99 Million |
| Net Income | -33.45 Million | -46.22 Million | -49.62 Million | -35.78 Million | -10.61 Million | -6.51 Million |
| Depreciation & Amortization | 364 Thousand | 2.49 Million | 2.61 Million | 2.09 Million | -485 Thousand | 1.12 Million |
| Deferred income taxes | - | 3.36 Million | - | 3.76 Million | -873 Thousand | -35.54 Million |
| Stock-based compensation | 1.71 Million | 2.93 Million | 4.62 Million | 2.18 Million | 1.15 Million | 532 Thousand |
| Change in working capital | -3.52 Million | 6.18 Million | 16 Thousand | 3.61 Million | -662 Thousand | 867 Thousand |
| Other non-cash items | 3.56 Million | -55 Thousand | -5.75 Million | -495 Thousand | 873 Thousand | 35.54 Million |
| Investing Cash Flow | -4000.00 | - | -694 Thousand | -741 Thousand | -485 Thousand | -13.04 Million |
| Investments in PPE | -4000.00 | - | -694 Thousand | -1.63 Million | -1.31 Million | -13.04 Million |
| Acquisitions | - | - | - | 472 Thousand | -122 Thousand | 11.98 Million |
| Investment purchases | - | - | - | -1.33 Million | -973 Thousand | -4.96 Million |
| Sales/Maturities of investments | - | - | - | 1 Million | 1 Million | 3.99 Million |
| Other Investing Activities | -4000.00 | - | -105 Thousand | 754 Thousand | 913 Thousand | -11.01 Million |
| Financing Cash Flow | 10.25 Million | 15.11 Million | 25.51 Million | 77.23 Million | 16.54 Million | 26.24 Million |
| Debt repayment | -1.66 Million | -4.28 Million | -18.02 Million | -202 Thousand | -255 Thousand | -438 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 13.62 Million | 19.56 Million | 9.21 Million | 77.23 Million | 16.37 Million | 26.68 Million |
| Other Financing Activities | 10.25 Million | -160 Thousand | 34.32 Million | 202 Thousand | 427 Thousand | -1.29 Million |
| Accounts receivables | 54 Thousand | 125 Thousand | -307 Thousand | -594 Thousand | -355 Thousand | - |
| Accounts payables | 106 Thousand | 80 Thousand | 1.41 Million | 782 Thousand | 355 Thousand | 302.95 Thousand |
| Inventory | - | 442 Thousand | -807 Thousand | -27 Thousand | -326 Thousand | - |
| Other working capital | -3.58 Million | 5.53 Million | -288 Thousand | 3.45 Million | -336 Thousand | 564.05 Thousand |
| Cash at beginning of period | 24.68 Million | 41.33 Million | 65.15 Million | 13.29 Million | 7.29 Million | 82 Thousand |
| Cash at end of period | 4.68 Million | 24.68 Million | 41.33 Million | 65.15 Million | 13.29 Million | 9.28 Million |
| Capital Expenditure | -4000.00 | - | -694 Thousand | -1.63 Million | -1.31 Million | -13.04 Million |
| Effect of forex changes on cash | -137 Thousand | 905 Thousand | -2.9 Million | 3.74 Million | -150 Thousand | -808 Thousand |
| Net cash flow / Change in cash | -20 Million | -16.65 Million | -23.82 Million | 51.86 Million | 5.99 Million | 9.2 Million |
| Free Cash Flow | -30.11 Million | -32.67 Million | -46.43 Million | -26.26 Million | -11.37 Million | -17.04 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.07 Million | -7.74 Million | -8.48 Million | -10.15 Million | -46.22 Million | -11.1 Million |
| Depreciation & Amortization | 60 Thousand | 69 Thousand | 108 Thousand | 127 Thousand | 2.49 Million | 120 Thousand |
| Deferred income taxes | - | - | -1.24 Million | 1.39 Million | 3.36 Million | -1.02 Million |
| Stock-based compensation | 419 Thousand | 671 Thousand | 97 Thousand | 523 Thousand | 2.93 Million | 574 Thousand |
| Change in working capital | -2.83 Million | 733.99 Thousand | -11.99 Thousand | -1.42 Million | 6.18 Million | 2.77 Million |
| Other non-cash items | 3.5 Million | -918.99 Thousand | 1.62 Million | 28 Thousand | -55 Thousand | 28 Thousand |
| Investing Cash Flow | -1000.00 | -3000.00 | -5002.00 | - | - | 59 Thousand |
| Investments in PPE | -1000.00 | -3000.00 | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 59 Thousand |
| Financing Cash Flow | 7.78 Million | 4.03 Million | -506.99 Thousand | -1.06 Million | 15.11 Million | -98 Thousand |
| Debt repayment | - | - | -599.99 Thousand | -1.06 Million | -4.28 Million | -82 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 8.46 Million | 4.02 Million | 93 Thousand | - | 19.56 Million | 145 Thousand |
| Other Financing Activities | -672 Thousand | 4.03 Million | 93 Thousand | -5000.00 | -160 Thousand | -161 Thousand |
| Accounts receivables | -168 Thousand | 815.99 Thousand | -356 Thousand | -237.99 Thousand | 125 Thousand | 322 Thousand |
| Accounts payables | - | 2.31 Million | -578 Thousand | 451.99 Thousand | 80 Thousand | -555 Thousand |
| Inventory | - | - | 1.00 | -1.00 | 442 Thousand | 4.06 Million |
| Other working capital | -2.66 Million | -2.4 Million | 922 Thousand | -1.63 Million | 5.53 Million | -1.05 Million |
| Cash at beginning of period | 4.7 Million | 5.61 Million | 13.89 Million | 24.68 Million | 41.33 Million | 33.02 Million |
| Cash at end of period | 4.68 Million | 4.7 Million | 5.61 Million | 13.89 Million | 24.68 Million | 24.68 Million |
| Capital Expenditure | -1000.00 | -3000.00 | - | - | - | - |
| Effect of forex changes on cash | 14 Thousand | -88 Thousand | 159 Thousand | -222 Thousand | 905 Thousand | 327 Thousand |
| Net cash flow / Change in cash | -24 Thousand | -915 Thousand | -8.27 Million | -10.79 Million | -16.65 Million | -8.34 Million |
| Free Cash Flow | -7.82 Million | -4.86 Million | -7.91 Million | -9.5 Million | -32.67 Million | -8.63 Million |
MESA
NWRN
2535
QUIA
9818
600120